Skip to main content
Year archive

EVE HEALTH GROUP LIMITED. — 2016 filings

All 74 regulatory filings released by EVE HEALTH GROUP LIMITED. (EVE) in 2016, sourced directly from the official regulator.

74 Filings
2016 Period
2016 filings (74)
Filing Released Lang
Update on Omni Innovation Investment 1 page 40.3KB
Capital/Financing Update
2016-12-29 English
$1.6m Placement for Omni Innovation Investment 1 pa
Capital/Financing Update
2016-12-22 English
Reinstatement to Official Quotation 1 page 86.5KB
Capital/Financing Update
2016-12-22 English
Prospectus 22 pages 259.4KB
Share Issue/Capital Change
2016-12-22 English
Appendix 3B 12 pages 257.9KB
Capital/Financing Update
2016-12-22 English
Net Tangible Asset Backing 1 page 24.3KB
Net Asset Value
2016-12-21 English
Suspension from Official Quotation 2 pages 355.8KB
Capital/Financing Update
2016-12-13 English
Withdrawal of Entitlement Issue 1 page 39.3KB
Capital/Financing Update
2016-12-13 English
Trading Halt 2 pages 114.3KB
Capital/Financing Update
2016-12-11 English
Notification of Rights Issue Shortfall 1 page 38.8K
Capital/Financing Update
2016-12-08 English
Omni Innovation Market Update 4 pages 198.4KB
Capital/Financing Update
2016-12-01 English
Rights Issue Offer Document 18 pages 562.4KB
Capital/Financing Update
2016-11-24 English
Becoming a Substantial Holder 2 pages 1.3MB
Regulatory Filings
2016-11-21 English
Results of Meeting 1 page 24.8KB
Declaration of Voting Results & Voting Rights Announcements
2016-11-21 English
Omni Innovation secures UK Distribution Deal 2 pages 47.9KB
Capital/Financing Update
2016-11-20 English
Letter to Shareholders 2 pages 131.6KB
Capital/Financing Update
2016-11-17 English
Appendix 3B 13 pages 242.9KB
Share Issue/Capital Change
2016-11-15 English
Non-Renounceable Rights Offer 2 pages 49.7KB
Capital/Financing Update
2016-11-15 English
Appendix 3B and Cleansing Notice 13 pages 249.4KB
Capital/Financing Update
2016-11-15 English
Letter to Optionholders 2 pages 133.1KB
Capital/Financing Update
2016-11-15 English
Net Tangible Asset Backing 1 page 24.4KB
Net Asset Value
2016-11-13 English
Placement to Chinese Pharmaceutical and Investment Group 2 pages 46.5KB
Capital/Financing Update
2016-11-09 English
Reinstatement to Official Quotation 1 page 256.6KB
Regulatory Filings
2016-11-09 English
Voluntary Suspension 2 pages 112.2KB
Regulatory Filings
2016-11-02 English
Appendix 4C - Quarterly 6 pages 70.3KB
Interim / Quarterly Report Q1 2016
2016-10-31 English
Trading Halt 2 pages 111.6KB
Regulatory Filings
2016-10-31 English
Annual Report to Shareholders 50 pages 4.8MB
Annual Report FY 2016
2016-10-20 English
Appendix 4G and Corporate Governance Statement 17 pages 230.6KB
Governance Information
2016-10-20 English
Notice of Annual General Meeting/Proxy Form 14 pages 242.6KB
AGM Information
2016-10-20 English
Net Tangible Asset Backing 1 page 24.3KB
Net Asset Value
2016-10-13 English
EVE Investments Webcast on Omniblend Innovation 1 p
Regulatory Filings
2016-10-12 English
Extension of Omniblend Innovation Tranche 2 Settlement 1
Capital/Financing Update
2016-09-29 English
New Study- GlucoControl Improves Long-Term Glycaemic Control 2 pages 50.2KB
Regulatory Filings
2016-09-20 English
Update on Omniblend Innovation 2 pages 48.6KB
Regulatory Filings
2016-09-13 English
Net Tangible Asset Backing 1 page 24.5KB
Net Asset Value
2016-09-08 English
Appendix 4E and Full Year Statutory Accounts 40 pages 800.8KB
Annual Report FY 2016
2016-08-31 English
Omniblend Innovation Enters into US Representation Deal 2 pages 45.6KB
Regulatory Filings
2016-08-23 English
Net Tangible Asset Backing 1 page 24.5KB
Net Asset Value
2016-08-11 English
Appendix 4C - Quarterly 7 pages 119.5KB
Interim / Quarterly Report Q4 2016
2016-07-26 English
Net Tangible Asset Backing 1 page 24.6KB
Net Asset Value
2016-07-13 English
Omniblend Innovation Appoints Director of Sales & Marketing 2 pages 46.2KB
Board/Management Information
2016-07-11 English
GlucoControl for type 2 diabetes named Product of the Month 2 pages 79.1KB
Regulatory Filings
2016-07-07 English
GlucoControl Momentum 2 pages 99.2KB
Regulatory Filings
2016-07-04 English
Net Tangible Asset Backing 1 page 24.5KB
Net Asset Value
2016-06-09 English
Results of Meeting 1 page 24.8KB
Declaration of Voting Results & Voting Rights Announcements
2016-05-30 English
Appendix 3B and Change of Director's Interest Notice x 3 19 pages 267.0KB
Share Issue/Capital Change
2016-05-30 English
Net Tangible Asset Backing 1 page 24.4KB
Net Asset Value
2016-05-12 English
Exclusive Engagement Signed with OHC for Scandinavia 1
Capital/Financing Update
2016-05-11 English
GlucoControl Pre-Meal Drink Launched 3 pages 191.8KB
Regulatory Filings
2016-05-05 English
Appendix 3B 13 pages 221.5KB
Share Issue/Capital Change
2016-05-02 English
Notice of General Meeting/Proxy Form 12 pages 261.8KB
Proxy Solicitation & Information Statement
2016-04-28 English
Appendix 4C - Quarterly 7 pages 106.1KB
Interim / Quarterly Report Q3 2016
2016-04-25 English
Omniblend Innovation Transaction Completed 2 pages 47.0KB
Capital/Financing Update
2016-04-21 English
Net Tangible Asset Backing 1 page 24.3KB
Net Asset Value
2016-04-14 English
Extension of Omniblend Innovation Tranche 2 Settlement 1
Capital/Financing Update
2016-03-31 English
Change in Substantial Holding 2 pages 98.1KB
Major Shareholding Notification
2016-03-31 English
Med-Tech Executive Joins EVE Board 6 pages 192.6KB
Board/Management Information
2016-03-30 English
Completion of $1.85M Non-Renounceable Rights Issue 1
Capital/Financing Update
2016-03-20 English
Net Tangible Asset Backing 1 page 24.4KB
Net Asset Value
2016-03-03 English
Half Yearly Report and Accounts 20 pages 738.6KB
Interim / Quarterly Report H1 2016
2016-02-29 English
GlucoControl Product Manufacturing Commences 2 pages 46.1KB
Capital/Financing Update
2016-02-24 English
Letter to Shareholders 2 pages 34.4KB
Capital/Financing Update
2016-02-21 English
Fully Underwritten Rights Issue 2 pages 49.7KB
Capital/Financing Update
2016-02-17 English
Prospectus 29 pages 244.6KB
Capital/Financing Update
2016-02-17 English
Appendix 3B 12 pages 219.3KB
Capital/Financing Update
2016-02-17 English
Letter to Optionholders 2 pages 34.2KB
Capital/Financing Update
2016-02-17 English
Net Tangible Asset Backing 1 page 24.4KB
Net Asset Value
2016-02-14 English
Investor Presentation - Omniblend Innovation Acquisition 17 pages 3.0MB
Investor Presentation
2016-02-02 English
Shareholder Update 2 pages 94.2KB
Capital/Financing Update
2016-02-01 English
Appendix 4C - Quarterly 6 pages 68.0KB
Interim / Quarterly Report Q2 2016
2016-01-28 English
Net Tangible Asset Backing 1 page 23.3KB
Net Asset Value
2016-01-12 English
Change in Substantial Holding 2 pages 98.2KB
Major Shareholding Notification
2016-01-11 English
Appendix 3B 13 pages 221.6KB
Capital/Financing Update
2016-01-03 English
Change of Director's Interest Notice x 2 4 pages 149.0KB
Director's Dealing
2016-01-03 English